Clinical Diagnosis of COVID-19: A Prompt, Feasible, and Sensitive Diagnostic Tool Based on a 1,757-Patient Cohort (The AndroCoV Clinical Scoring for COVID-19 Diagnosis)

    January 2021 in “ medRxiv (Cold Spring Harbor Laboratory) ”
    Flavio Cadegiani, J. Philip McCoy, Carlos Gustavo Wambier, Andy Goren

    Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

    Studysummary This study reports that the AndroCoV Clinical Scoring for COVID-19 Diagnosis provides a quicker, more sensitive, and inexpensive alternative to rtPCR-SARS-CoV-2 with an accuracy above 80% in diagnosing COVID-19.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on medrxiv.org →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin, or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients bioRxiv (Cold Spring Harbor Laboratory) · 2020
    2. Hydroxychloroquine, Nitazoxanide, and Ivermectin Have Similar Effects in Early COVID-19: A Head-to-Head Comparison of the Pre-AndroCoV Trial Research Square (Research Square) · 2020
    3. Azithromycin With Nitazoxanide, Hydroxychloroquine or Ivermectin, With or Without Dutasteride, for Early Stage COVID-19: An Open-Label Prospective Observational Study in Males With Mild-to-Moderate COVID-19 (The Pre-AndroCoV Male Trial) Research Square (Research Square) · 2020
    4. An Open-Label Prospective Observational Study of Antiandrogen and Non-Antiandrogen Early Pharmacological Approaches in Females with Mild-to-Moderate COVID-19: The Pre-AndroCoV Female Trial medRxiv (Cold Spring Harbor Laboratory) · 2020
    5. Repurposing Existing Drugs for COVID-19: An Endocrinology Perspective BMC Endocrine Disorders · 2020